nCPAP treatment interruption in OSA patients

Area of Science:

• Sleep Medicine
• Respiratory Medicine
• Cardiology

Background:

• Obstructive sleep apnoea (OSA) is a common condition characterized by repeated upper airway collapse during sleep.
• Nasal continuous positive airway pressure (nCPAP) is a primary treatment for OSA, maintaining airway patency.
• Long-term adherence and potential effects of nCPAP interruption in established OSA patients require further investigation.

Purpose of the Study:

• To evaluate the impact of discontinuing nCPAP therapy on sleep parameters and gas exchange in patients with a history of OSA.
• To determine the immediate consequences of nCPAP withdrawal on apnoea-hypopnoea index (AHI) and blood gas levels.

Main Methods:

• A study involving 10 OSA patients (mean age 53.6 years) with over 2 years of nCPAP treatment.
• Monitoring sleep parameters and gasometric values over five consecutive nights.
• Comparing the first night of habitual nCPAP use with the subsequent four nights of nCPAP interruption.

Main Results:

• A significant increase in the apnoea-hypopnoea index (AHI) was observed from the second night of nCPAP withdrawal.
• Minimum oxygen saturation (SaO2) decreased, while partial pressure of carbon dioxide (PaCO2) increased significantly on the second night compared to the first.
• Gasometric parameters and sleep counts deteriorated rapidly upon nCPAP cessation.

Conclusions:

• Interruption of long-term nCPAP therapy in OSA patients leads to a rapid decline in sleep quality and gasometric stability.
• Even short periods of nCPAP cessation can negate the benefits of prolonged treatment, increasing AHI and worsening respiratory parameters.
• Careful monitoring and management are crucial when considering any alterations to nCPAP therapy duration in OSA patients to prevent adverse effects.